Massachusetts Cannabis Commission Claims Oversight of Intoxicating Hemp

“When I look at this from a social justice perspective, we are being intentional with where we have potential revenue and cash flow really circulating in an industry that needs that type of capital infusion,” Commissioner Xiomara DeLobato said Tuesday, as the Massachusetts Cannabis Control Commission voted unanimously to claim oversight of the state’s intoxicating hemp market.

The decision, first reported by The Boston Globe and detailed by the Boston Globe, pulls products that have proliferated in legal gray areas for years under the same regulatory roof as adult-use cannabis.

Commissioners agreed the CCC — not the Department of Agricultural Resources or a new standalone body — should license, test, and enforce age limits on hemp-derived cannabinoids that get users high, while routing non-intoxicating hemp goods through the existing cannabis supply chain for sale both inside and outside licensed dispensaries. The agriculture department would keep authority over cultivation, a split that mirrors Michigan’s approach.

The move matters because Massachusetts regulators are now moving to address a regulatory gap in the intoxicating hemp market. Hemp was defined federally as cannabis with no more than 0.3 percent delta-9 THC by dry weight, but the statute said nothing about isomers like delta-8, delta-10, or THC-O synthesized from legal hemp.

Entrepreneurs flooded gas stations, smoke shops, and online storefronts with intoxicating edibles and vapes that bypassed the CCC’s seed-to-sale tracking, mandatory lab testing, and 21-plus age gates. Massachusetts lawmakers finally ordered the commission to study the problem in Section 64 of Chapter 65 of the Acts of 2026, the cannabis reform bill signed in April.

Massachusetts Cannabis Commission Claims Oversight of Intoxicating Hemp
Photo: bostonglobe.com

The commission’s draft report, posted ahead of Tuesday’s meeting and titled “Study and Recommendations Regarding the Effective Regulation of the Hemp-Derived Cannabinoid Market in Massachusetts,” does not endorse a single framework. Instead, it lays out four models for legislators to choose from. Model 1 restricts all intoxicating hemp products to CCC-licensed retailers.

Model 2 tiers rules by potency and product form. Model 3 creates a separate cannabinoid-hemp license category — the path New York took. Model 4 leans on THC thresholds and product categories to decide which rules apply, similar to Connecticut’s system. Commissioners signaled Tuesday they favor Model 1’s restricted retail approach, but the final choice belongs to the General Court.

“We’re striking a balance here by requiring strict security around drive-thru service subject to local control while allowing licensees to offer their customers and patients more convenience.”

CCC Chair Chris Harding said in a commission statement, announcing a parallel vote Tuesday that cleared adult-use retailers and medical dispensaries to apply for drive-thru windows. The approval comes with a checklist: verify every occupant’s age before they enter the lane and again at the window, keep cameras on the drive-thru at all times, ensure products are never visible through the glass, conduct no transactions in public view, post signage spelling out the rules, and secure municipal sign-off.

The Globe noted the commission sees the two votes as complementary — tightening the regulated market while giving legal operators new ways to compete with the unregulated sellers the hemp rules target.

Massachusetts cannabis regulator moves to police intoxicating hemp products statewide
Photo: hoodline.com

CannabisNews.org reported that the draft report also flags the federal backdrop shifting under the state’s feet. A law signed November 12, 2025 — Public Law 119-37 — rewrote the federal hemp definition to exclude cannabinoids synthesized outside the plant and any product with quantifiable THC or similar-effect cannabinoids. That amendment took effect November 12, 2026, narrowing the category that let the intoxicating hemp market bloom.

Hoodline highlighted that the commission’s assignment goes beyond picking an agency. The statute demands recommendations on licensing conditions, testing standards, age-verification safeguards, retail channels, taxation, and a survey of how other states handle ingestible hemp.

The CCC must publish its findings and deliver them to the Senate and House clerks and the Joint Committee on Cannabis Policy by December 15. Staff will present draft regulations at the commission’s December 10 meeting, giving lawmakers a concrete starting point for the 2027 legislative session.

The split oversight — agriculture for farming, CCC for finished intoxicating products — drew no dissent Tuesday, but the second half of the commission’s recommendation will require a statutory change.

Letting non-intoxicating hemp products like CBD tinctures or topicals be sold outside CCC-licensed stores, in grocery aisles or wellness shops, needs legislative approval. DeLobato argued the expanded footprint would build brand recognition for cannabis manufacturers and steer revenue toward social-equity licensees who have struggled to access capital.

The CCC’s December 10 draft regulations and December 15 legislative report are the next mile markers.